ARTICLE | Clinical News
PKX-001: Ph I started
March 14, 2017 7:56 PM UTC
ProtoKinetix began an open-label, Canadian Phase I trial to evaluate transplanted islet cells treated with PKX-001 in up to 10 patients....
BCIQ Company Profiles
ProtoKinetix began an open-label, Canadian Phase I trial to evaluate transplanted islet cells treated with PKX-001 in up to 10 patients....
BCIQ Company Profiles